Cva Family Office, LLC Biogen Inc. Transaction History

Cva Family Office, LLC

$606 Million
Q3 2024

A detailed history of Cva Family Office, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Cva Family Office, LLC holds 115 shares of BIIB stock, worth $19,985. This represents 0.0% of its overall portfolio holdings.

Number of Shares

115

Previous 313 63.26%

Holding current value

$19,985

Previous $72,000 69.44%

% of portfolio

0.0%

Previous 0.01%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	SELL	$189.07 - $236.8 $37,435 - $46,886	-198 Reduced 63.26%	115 $22,000
Q2 2024 Jul 09, 2024	BUY	$190.52 - $236.72 $32,578 - $40,479	171 Added 120.42%	313 $72,000
Q1 2024 Apr 10, 2024	BUY	$212.02 - $267.71 $424 - $535	2 Added 1.43%	142 $30,000
Q4 2023 Jan 16, 2024	BUY	$222.59 - $267.94 $31,162 - $37,511	140 New	140 $36,000
Q2 2023 Jul 10, 2023	BUY	$275.25 - $318.06 $2,752 - $3,180	10 Added 9.52%	115 $32,000
Q1 2023 Apr 26, 2023	SELL	$256.56 - $292.34 $5,131 - $5,846	-20 Reduced 16.0%	105 $29,000
Q4 2022 Feb 21, 2023	BUY	$252.44 - $306.72 $5,048 - $6,134	20 Added 19.05%	125 $34,000
Q3 2022 Nov 22, 2022	BUY	$194.69 - $268.46 $6,814 - $9,396	35 Added 50.0%	105 $28,000
Q2 2022 Jul 11, 2022	SELL	$187.54 - $223.02 $4,688 - $5,575	-25 Reduced 26.32%	70 $14,000
Q1 2022 Apr 22, 2022	BUY	$193.77 - $244.14 $968 - $1,220	5 Added 5.56%	95 $20,000
Q4 2021 Jan 25, 2022	BUY	$223.92 - $287.77 $20,152 - $25,899	90 New	90 $22,000
Q3 2021 Oct 12, 2021	SELL	$282.99 - $369.05 $41,033 - $53,512	-145 Closed	0 $0
Q2 2021 Jul 13, 2021	BUY	$259.0 - $414.71 $9,065 - $14,514	35 Added 31.82%	145 $50,000
Q1 2021 Apr 14, 2021	BUY	$242.95 - $284.63 $26,724 - $31,309	110 New	110 $31,000

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cva Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cva Family Office, LLC with notifications on news.

Account

Cva Family Office, LLC Biogen Inc. Transaction History